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PRESENTING IGNORANCE: A POSSIBILITY INTERVAL
APPROACH TO DEPICT HIGH-LEVEL UNCERTAINTY DUE TO
CENSORING OR NON-RESPONDENTS
Turunen JH1, Soini EJ2
1Equal contribution of both authors. Department of Social Pharmacy,
University of Kuopio, Kuopio, Finland, 2Department of Social
Pharmacy, Department of Health Policy and Management, University
of Kuopio, Kuopio, Finland
Model veriﬁcation/validation applies the metrics of prediction
error (e.g. area under curve), information criterion (e.g. Akaike,
Bayesian, deviance), model uncertainty (e.g. substitution, por-
tioning, leave-one-out/K-fold cross-validation), and numerical
convergence. However, censoring and non-respondents cause
uncertainty in follow-up studies and surveys. When missing at
completely random (MACR) is not true, empirical result veriﬁ-
cation is problematic. Thus, emphasis should be given on ways
to illustrate ignorance related to missing values. OBJECTIVES:
To present a possibility interval (PI) and its relation to Wald con-
ﬁdence intervals (CI) and Jeffreys Bayesian credibility intervals
(CrI; Beta 0.5, 0.5 a priori) in 9 artiﬁcial samples of 1000 indi-
viduals (prevalence of e.g. drug utilization 10%–50%; ignorance
due to censoring/non-responding 5%–25%). METHODS: The
epistemic uncertainty is considered here as sampling ignorance.
The conjunctive set of points comprised in an interval of
minimum necessary level (NL) and maximum possibility level
(PL) constitute a PI (i.e. where the “true” mean must be condi-
tional to sample’s representativeness). Firstly, in possibility quan-
tiﬁcation, certainty sources (e.g. certain observations) are
determined. Secondly, the dominant possibility factors causing
ignorance are identiﬁed. Thirdly, NL and PL bounds are estab-
lished for parameters representing the outcome/model.
RESULTS: The NL and PL of PI depict the depth of ignorance.
In the artiﬁcial samples of e.g. 1000 potential drug users, PI over-
lapping was related to the levels of prevalence and ignorance. If
e.g. 10% difference in prevalence is observed between compared
groups, 15% ignorance constitutes a threshold for inference
change. In a case of 50% prevalence with ignorance between
approximately 5%–10%, PIs were visually in substitutive rela-
tion to CIs and CrIs. In other cases, PIs provide complementary
information. CONCLUSIONS: The complementary information
provided by PIs is important with higher (e.g. >10%) censoring
levels and, most importantly, if MACR does not hold or the
prevalence of research subject is very different from 50%.
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INDIRECT COSTS OF COMMON COLD IN GERMANY
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University of Duisburg-Essen, Essen, Germany
OBJECTIVES: To estimate the indirect costs caused by produc-
tivity loss due to simple infections of the upper respiratory tract
in Germany. METHODS: A representative sample of the
working population deﬁned by membership in the social insur-
ance in Germany (n = 994) was interviewed concerning the
annual incidence, work-off days and days at work with limited
productivity. The sample was representative concerning age, sex
and social status, and stratiﬁed by age, sex, region (eastern and
western part of Germany) and working status e.g. employee,
worker, trainee etc. Productivity losses were valued using the
human capital approach (HC) and the friction cost method (FC).
Data were extracted from different German administrative
sources like the federal institute for statistics. RESULTS: The
mean number of work-off days was 2.9 d. At 11.6 d per year the
productivity was limited by 35% due to a cold. The total annual
productivity loss per person was 7 d. The mean costs per working
person were €1009 (HC) respectively €807 (FC) using stratiﬁed
mean incomes of year 2004. Aggregated to the total working
population of Germany the indirect costs of illness in 2004 were
about 29.2 billion € (HC) respectively 23.3 billion € (FC). There
was a clear trend to lower cost in men and in younger age groups.
CONCLUSIONS: Although the direct medical costs per person
for the treatment of common cold without complications are
low, the high incidence of the disorder induces impressively high
indirect costs caused by short-time work-off and a relevant
number of days at work with a limited productivity due to a
cold.
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IMPLEMENTING NATURAL HISTORY STUDIES IN EURASIA:
THE NIEMANN-PICK EXPERIENCE WITH RAPIDLY
CHANGING NATIONAL REGULATIONS
Madison M1, Finegan Y1, Sawyer R2, Koval S2, Cox G2
1Abt Associates Inc, Lexington, MA, USA, 2Genzyme Corporation,
Cambridge, MA, USA
OBJECTIVE: Characterizing morbidity and mortality in rare
genetic diseases is challenging given the small numbers of
patients, their wide geographic distribution, and the variable
effects of genetic mutations. Global natural history studies aim
to close the knowledge gap but require the participation of 
multiple countries to achieve this goal. METHODS: In 2006,
Genzyme Corporation initiated a retrospective natural history
feasibility study of acid sphingomyelinase deﬁciency (ASMD,
also known as Niemann Pick disease Types A and B) in 8
Eurasian countries. ASMD is an inherited lysosomal storage dis-
order that affects approximately 2000 patients in developed
countries and has no speciﬁc treatment. The goal of the study
was to determine whether investigators would be able to imple-
ment a medical record abstraction study of ASMD. The objec-
tive of the post-feasibility study is to provide improved estimates
of morbidity and mortality that can help facilitate drug devel-
opment. RESULTS: Eurasian investigators were enthusiastic
about participating in and improving knowledge on this rare and
life-threatening disease, but they were cautious about interpret-
ing existing/evolving regulations for each country. Some coun-
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